Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer
Nap
Chronic gastritis
Interleukin 8
DOI:
10.3748/wjg.15.2381
Publication Date:
2009-05-20T02:35:47Z
AUTHORS (5)
ABSTRACT
AIM:To detect and evaluate the antibodies against Helicobacter pylori (H ) neutrophil-activating protein (HP-NAP) in patients with gastric cancer other gastroduodenal diseases. METHODS:Recombinant HP-NAP was prepared from a prokaryotic expression system Escherichia coli .Serum positivity level of HP-NAP-specific sera 43 cancer, 28 chronic gastritis, peptic ulcer, 89 healthy controls were measured by rHP-NAP-based ELISA.rHP-NAP-stimulated production interleukin-8 (IL-8) growth-related oncogene (GROα) cytokines culture supernatant SGC7901 epithelial cells also detected. RESULTS:The serum mean absorbance value c n e r g o u p ( 9 7.7 % d 1 .0 ± 0 . 2 4 w significantly higher than those gastritis group (85.7% 0.89 0.14, P < 0.005) control (27.7% 0.65 0.18, 0.001).The sensitivity specificity ELISA for detection 95.5% 91.5%, respectively.HP-NAP could slightly upregulate IL-8 cell lines but had no effect on GROα production. CONCLUSION:Infection virulent H strains secreting is associated severe diseases, may play role development carcinoma.rHP-NAPbased can be used as new method to infection.The direct limited, contribute inflammatory response or carcinogenesis activating neutrophils.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (14)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....